STAGE IIIA BLADDER CANCER AJCC V8
Clinical trials for STAGE IIIA BLADDER CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIA BLADDER CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IIIA BLADDER CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for Hard-to-Treat cancers, but study ends early
Disease control TerminatedThis early-phase study tested a drug called plinabulin combined with radiation and immunotherapy in 19 people with advanced cancers (like lung, bladder, or melanoma) that had stopped responding to standard immunotherapy. The goal was to see if the combo could shrink tumors or slo…
Matched conditions: STAGE IIIA BLADDER CANCER AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 06:44 UTC
-
Bladder cancer drug trial halted early after only 4 patients
Disease control TerminatedThis early-phase trial tested whether a targeted chemotherapy drug (sacituzumab govitecan) given before bladder removal surgery could improve outcomes for people with a rare type of muscle-invasive bladder cancer. The study planned to enroll about 20 participants but was stopped …
Matched conditions: STAGE IIIA BLADDER CANCER AJCC V8
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated May 15, 2026 11:57 UTC